Who
Nancy Whiting
Director
Company insider
Files Form 4 as: Director, Boundless Bio; Director, Caribou Biosciences.
In numbers
- Trades disclosed
- 12
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 8 Sep 2021
- Last trade
- 15 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jun 2026filed 15 Jun 2026 | BOLD Boundless Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —32,000 at $0.00 | filing |
| 15 Jun 2026filed 15 Jun 2026 | BOLD Boundless Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —32,000 at $0.00 | filing |
| 20 Feb 2026filed 20 Feb 2026 | CRBU Caribou Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 20 Feb 2026filed 20 Feb 2026 | CRBU Caribou Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 23 Jun 2025filed 23 Jun 2025 | BOLD Boundless Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
| 20 Feb 2025filed 21 Feb 2025 | CRBU Caribou Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,500 at $0.00 | filing |
| 27 Mar 2024filed 29 Mar 2024 | BOLD Boundless Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —13,219 at $0.00 | filing |
| 20 Feb 2024filed 22 Feb 2024 | CRBU Caribou Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —39,500 at $0.00 | filing |
| 21 Feb 2023filed 23 Feb 2023 | CRBU Caribou Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,500 at $0.00 | filing |
| 20 Dec 2021filed 22 Dec 2021 | CRBU Caribou Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,060 at $0.00 | filing |
| 20 Dec 2021filed 21 Dec 2021 | CRBU Caribou Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,750 at $0.00 | filing |
| 8 Sep 2021filed 9 Sep 2021 | CRBU Caribou Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.